The Venture Codex Logo

The Venture Codex

Silverback Therapeutics

500 Fairview Avenue North, Suite 600, Seattle, WA, 98109, United States

Overview

Biopharmaceutical company developing targeted ImmunoTAC therapies.

Total Raised

$201 M

Rounds

3

Links

Verticals

Biopharma
Biotechnology
Health Care
Medical
Therapeutics

Investment History

  1. Series C

    Sep 2020

    $85M

    OrbiMedEcoR1 Capital · LeadPontifaxRA Capital ManagementFidelity Management & Research CompanyNextech InvestU.S. Venture Partners

  2. Series B

    Mar 2020

    $79M

    U.S. Venture Partners · LeadNS InvestmentHunt Investment GroupOrbiMedBristol Myers SquibbColt VenturesNextech InvestPontifaxAlexandria Venture Investments

  3. Series A

    Sep 2018

    $38M

    OrbiMedAlexandria Venture InvestmentsCelgene

Team

Peter Thompson

Co-Founder, Chairman, CEO

Laura Shawver

President and CEO

Graham Jang

Vice President, Development Sciences

Sateesh Natarajan

Vice President, Product Development